drugset / Trial / NCT01216163

Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain

NCT01216163 ↗

Phase 3 Completed 218 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will compare the analgesic efficacy of a single-dose of a novel ibuprofen formulation to placebo and acetaminophen in the treatment of post-surgical dental pain following "wisdom" tooth (third molar) removal.

Timeline

Start
2010-10
Primary completion
2011-01
Completion
2011-01

Outcome

Met primary endpoint

registry Placebo vs Ibuprofen Sodium; p <0.001; Least-squares (LS) mean difference 17.68 (95% CI 13.08 to 22.27) NCT01216163 ↗

registry Placebo vs Ibuprofen Sodium; p <0.001; Hazard Ratio (HR) 11.84 (95% CI 5.13 to 27.36) NCT01216163 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 1000 mg —
Subject Ibuprofen Small molecule 512 mg —

Indications

No indication recorded.